ShRNA-mediated silencing of hTERT promote apoptosis and senescence in human ovarian cancer cells
Authors:
Open Access
- 1 April 2019
- journal article
- research article
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 8 (2) , 567-573
Abstract
Background: Human telomerase reverse transcriptase (hTERT) is a crucial oncogene and a key factor in cell immortalization. Apart from hematopoiesis stem cell and germ cells, normal cells and tissues almost no expression of this gene. However, the positive expression rate of hTERT in malignant tumors is as high as 80–95%. This study was designed to investigate the mechanism of knockdown of hTERT expression in the regulation of ovarian cancer carcinogenesis in nude mice transplantation model. Methods: We identified the function of hTERT in the treatment of ovarian cancer by constructing a nude mice transplantation tumor model. Then analyzed the mechanism of hTERT in modulating ovarian cancer cell apoptosis and senescence by immunohistochemically staining. Results: Our analysis identified hTERT as a novel regulator of ovarian cancer progression and is one of the most significantly upregulated genes in ovarian cancer. Down-regulation of hTERT inhibits proliferation of ovarian cancer cells by promoting apoptosis and the expression of the senescence gene p53 and p21. Conclusions: hTERT is a key oncogene in ovarian tumorigenesis and metastasis; the downregulation of hTERT significantly inhibit the proliferation of ovarian cancer and have an effect on treatment of ovarian cancer by activating cell apoptosis and senescence pathway.Keywords
This publication has 17 references indexed in Scilit:
- Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cellsMolecular and Cellular Endocrinology, 2017
- Telomere-driven diseases and telomere-targeting therapiesJournal of Cell Biology, 2017
- Regulation of the Human Telomerase Gene TERT by Telomere Position Effect—Over Long Distances (TPE-OLD): Implications for Aging and CancerPLOS Biology, 2016
- Non-Canonical Cell Death Induced by p53International Journal of Molecular Sciences, 2016
- Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapiesGenome Medicine, 2016
- Broad targeting of resistance to apoptosis in cancerSeminars in Cancer Biology, 2015
- Expression of phosphorylated Akt and hTERT is associated with prognosis of epithelial ovarian carcinoma.2015
- Human telomerase reverse transcriptase expression in ovarian tumorsIndian Journal of Pathology and Microbiology, 2012
- Hallmarks of telomeres in ageing researchThe Journal of Pathology, 2007
- Effect of penclomedine (NSC-338720) on telomere fusions, chromatin blebbing, and cell viability with and without telomerase activity and abrogated p53 functionBiochemical Pharmacology, 1997